Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dow Inc (DOW) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Dow Inc vs uniQure N.V. Ordinary Shares — how do they compare? Dow Inc trades at $29.46 (market cap $21.09B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Dow Inc is far larger — about 14.5× uniQure N.V. Ordinary Shares's market cap, and Dow Inc pays a 4.8% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dow Inc for 83 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

DOWQURE
Market Cap
$21.09B$1.45B
Volume
8,218,3993,323,243
Sector
Basic MaterialsHealth
52-Week High
$41.87$70.59
52-Week Low
$20.95$9.03
Typical Hold Time
83 Days0 Days
Enterprise Value
$36.78B$707.46M
Dividend Yield
4.8%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dow Inc

DOW trades at $28.51, up 1.39% with bearish technical signals despite recent earnings beats. The company faces fundamental challenges with negative net income margin (-3.13%) and ROE (-7.86%), though valuation metrics show moderate P/S (0.5) and P/B (1.3). Cash flow trends show improvement with 2025 net cash flow turning positive at $1.69B after three years of declines. Recent news highlights dividend sustainability concerns in the chemical sector.

Outlook remains cautious with analyst consensus at Hold (55.55%) and $33.80 price target offering 18.6% upside. Key risks include continued margin pressure, declining revenue trends, and high debt levels (debt-to-asset ratio 29.87%). The stock presents value opportunity for patient investors but requires monitoring of operational turnaround and dividend sustainability.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DOW
0% Buy100% Sell
Avg holding period · 83 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

About Dow Inc

Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.

Read more on DOW →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →